Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 9
2003 30
2004 36
2005 28
2006 45
2007 38
2008 64
2009 106
2010 101
2011 127
2012 169
2013 170
2014 227
2015 210
2016 279
2017 269
2018 313
2019 362
2020 460
2021 454
2022 572
2023 546
2024 586
2025 718
2026 473

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,711 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. Among authors: zhang w. N Engl J Med. 2025 Mar 27;392(12):1168-1177. doi: 10.1056/NEJMoa2409712. Epub 2024 Nov 14. N Engl J Med. 2025. PMID: 39541094 Clinical Trial.
Instant assembly of collagen for tissue engineering and bioprinting.
Gong X, Wen Z, Liang Z, Xiao H, Lee S, Rossello-Martinez A, Xing Q, Wright T, Nguyen RY, Mak M. Gong X, et al. Among authors: wen z. Nat Mater. 2025 Aug;24(8):1307-1318. doi: 10.1038/s41563-025-02241-7. Epub 2025 Jun 6. Nat Mater. 2025. PMID: 40481243
Obexelimab for the Treatment of IgG4-Related Disease.
Della-Torre E, Baker MC, Zhang W, Perugino CA, Katz G, Tanaka Y, Khosroshahi A, Kleger A, Schleinitz N, Martinez-Valle F, Schulze-Koops H, Nakayamada S, Rebours V, Okazaki K, Dong L, Carruthers M, Chen LYC, Frulloni L, Meysami A, Takahashi H, Kawano M, Liu Y, Saeki T, Ebbo M, Alexander T, González García A, Karadag O, Maślińska M, Quinn SM, Poma A, Wells A, Greene TJ, Stone JH, Culver EL; INDIGO Trial Investigators. Della-Torre E, et al. Among authors: zhang w. N Engl J Med. 2026 Jun 2. doi: 10.1056/NEJMoa2601337. Online ahead of print. N Engl J Med. 2026. PMID: 42233621
Optimization of Vascularized Intestinal Organoid Model.
Wen Z, Orduno M, Liang Z, Gong X, Mak M. Wen Z, et al. Adv Healthc Mater. 2024 Dec;13(31):e2400977. doi: 10.1002/adhm.202400977. Epub 2024 Aug 1. Adv Healthc Mater. 2024. PMID: 39091070 Free PMC article.
5,711 results